[Treatment of chronic myeloid leukemia with Dibromomannitol].
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001966:Bromine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008297:Male; D008353:Mannitol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D013997:Time Factors
D000970:Antineoplastic Agents; D008353:Mannitol; D001966:Bromine
Traitement de la leucémie myéloide chronique par le Dibromomannitol.